Vanguard Portfolio Management
MXCT icon

Vanguard Portfolio Management’s MaxCyte MXCT Stock Holding History

Vanguard Portfolio Management’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$320K Sell
260,443
-628,797
-71% -$627K ﹤0.01% 3094
2026
Q1 		$625K Buy
+889,240
New +$830K ﹤0.01% 2919

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Vanguard Portfolio Management's MXCT Position: Q2 2026 in Review

Vanguard Portfolio Management reduced its MaxCyte (MXCT) stake by 71% in Q2 2026, selling an estimated $627K and leaving 260,443 shares worth $320K. The position accounts for ﹤0.01% of the portfolio, ranked #3094.

Vanguard Portfolio Management first reported a position in MXCT in Q1 2026 and has held it in 2 quarters since. The position peaked at $625K in Q1 2026. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Vanguard Portfolio Management held 260,443 shares of MaxCyte worth $320K as of Q2 2026.
  • Vanguard Portfolio Management sold 628,797 MaxCyte shares in Q2 2026, an estimated $627K.
  • MaxCyte made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #3094 holding.
  • Vanguard Portfolio Management first reported a position in MaxCyte in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Portfolio Management's MaxCyte position peaked at $625K in Q1 2026.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.